PAQ Therapeutics

PAQ Therapeutics is a biotechnology company that has pioneered a new approach to restoring health and curing diseases through autophagy, the most versatile natural cellular degradation mechanism in the human body. Using our ATTEC (autophagosome-tethering compound) technology, we are developing a novel class of small-molecule degraders capable of linking various substrates to the autophagy pathway. PAQ’s research progress is driving an important new type of degradation therapy, which has the potential to fundamentally transform drug discovery and development, targeting a range of substrates including proteins, aggregates, lipids, organelles, and pathogens.